Laurence Desjardins Selected Research

Laurence Desjardins Research Topics

Disease

30	Neoplasms (Cancer) 01/2021 - 04/2002
16	Retinoblastoma (Glioblastoma, Retinal) 01/2021 - 04/2002
13	Melanoma (Melanoma, Malignant) 10/2019 - 08/2002
12	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2006
12	Uveal melanoma 07/2019 - 07/2006
4	Retinal Detachment (Retinal Detachments) 02/2018 - 07/2006
3	Cicatrix (Scar) 01/2021 - 01/2012
3	Hemangioma (Angioma) 04/2019 - 02/2009
3	Neovascular Glaucoma 02/2018 - 01/2012
2	Necrosis 01/2022 - 12/2008
2	Glaucoma 10/2019 - 03/2019
2	Rhabdomyosarcoma 11/2014 - 12/2003
1	Fistula 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Cataract (Cataracts) 10/2019
1	Amelanotic Melanoma (Amelanotic Melanomas) 03/2019
1	Breast Neoplasms (Breast Cancer) 10/2018
1	Hemorrhage 04/2018
1	Hypertension (High Blood Pressure) 02/2018
1	Sturge-Weber Syndrome (Sturge-Kalischer-Weber Syndrome) 01/2018
1	Neoplasm Micrometastasis 05/2017
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2017
1	Vitreous Hemorrhage 07/2014
1	Macular Edema 07/2014
1	Telangiectasis (Telangiectasia) 07/2014
1	Epiretinal Membrane (Epiretinal Membranes) 07/2014
1	Circulating Neoplastic Cells 03/2014
1	Toxic Optic Neuropathy 02/2014
1	Aneuploidy (Aneuploid) 10/2013
1	Margins of Excision 04/2013
1	Sympathetic Ophthalmia (Sympathetic Uveitis) 08/2012
1	Inflammation (Inflammations) 01/2012
1	Residual Neoplasm 01/2012
1	Corneal Diseases (Corneal Disease) 12/2011
1	Adenoid Cystic Carcinoma (Cylindroma) 11/2011
1	Keratoconus 08/2011
1	Hearing Loss (Hearing Impairment) 05/2009
1	High-Frequency Hearing Loss 05/2009
1	Ototoxicity 05/2009
1	Sarcoma (Soft Tissue Sarcoma) 08/2006
1	Second Primary Neoplasms (Neoplasms, Second) 06/2006

Drug/Important Bio-Agent (IBA)

10	Protons (Proton)IBA 07/2019 - 07/2006
6	Retinaldehyde (Retinal)IBA 01/2021 - 07/2006
5	Biological ProductsIBA 01/2021 - 04/2010
3	Biomarkers (Surrogate Marker)IBA 05/2017 - 03/2014
3	IodineIBA 12/2008 - 04/2002
2	Dihydrotachysterol (AT 10)IBA 04/2016 - 01/2012
2	Circulating Tumor DNAIBA 03/2014 - 07/2012
2	Proteins (Proteins, Gene)FDA Link 06/2013 - 02/2011
2	Carboplatin (JM8)FDA LinkGeneric 05/2009 - 08/2008
2	CobaltIBA 02/2009 - 12/2008
2	Etoposide (VP 16)FDA LinkGeneric 08/2008 - 12/2003
1	Drug CombinationsIBA 01/2021
1	InterferonsIBA 01/2021
1	Bevacizumab (Avastin)FDA Link 02/2018
1	beta Subunit Luteinizing HormoneIBA 01/2018
1	Melphalan (Alkeran)FDA LinkGeneric 07/2017
1	SuspensionsIBA 01/2017
1	Alkaline PhosphataseIBA 08/2016
1	Everolimus FDA Link 12/2014
1	NucleotidesIBA 10/2013
1	Messenger RNA (mRNA)IBA 06/2013
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 04/2013
1	DNA (Deoxyribonucleic Acid)IBA 07/2012
1	CytokinesIBA 01/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012
1	AldehydesIBA 12/2011
1	Oxidoreductases (Dehydrogenase)IBA 12/2011
1	RNA (Ribonucleic Acid)IBA 08/2011
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 08/2011
1	Protein Tyrosine PhosphatasesIBA 02/2011
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2011
1	fotemustine (Muphoran)IBA 04/2010
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2010
1	Temozolomide (Temodar)FDA LinkGeneric 04/2010
1	Complementary DNA (cDNA)IBA 04/2007
1	Cisplatin (Platino)FDA LinkGeneric 12/2003
1	Dactinomycin (Actinomycin)FDA LinkGeneric 12/2003
1	Dacarbazine (DIC)FDA LinkGeneric 12/2003

Therapy/Procedure

19	Radiotherapy 01/2022 - 12/2003
13	Therapeutics 03/2019 - 12/2003
9	Drug Therapy (Chemotherapy) 01/2021 - 04/2002
9	Proton Therapy 10/2019 - 07/2006
6	Conservative Treatment 01/2021 - 08/2008
6	Aftercare (After-Treatment) 06/2014 - 04/2002
4	Induced Hyperthermia (Thermotherapy) 07/2013 - 04/2002
3	Neoadjuvant Therapy 01/2020 - 08/2008
2	Brachytherapy 10/2018 - 01/2012
2	Combination Drug Therapy (Combination Chemotherapy) 11/2014 - 12/2003
2	Lasers (Laser) 07/2014 - 06/2002
2	Light Coagulation 07/2014 - 04/2002
2	Semiconductor Lasers 06/2002 - 04/2002
1	Immunotherapy 10/2018
1	Injections 01/2017
1	Vitrectomy 07/2014
1	Slit Lamp 07/2014
1	Adjuvant Chemotherapy 04/2013
1	Consolidation Chemotherapy 04/2013
1	Intravitreal Injections 01/2012
1	Hearing Aids (Hearing Aid) 05/2009